Table 1 Demographic and disease characteristics of patientsa at study entry
IM IFNβ-1a (n = 82) | SC IFNβ-1b (n = 123) | SC IFNβ-1a (n = 184) | SC GA (n = 23) | Overall (N = 412) | |
|---|---|---|---|---|---|
Mean age, years (SD) | 44.7 (10.35) | 45.9 (10.23) | 43.2 (9.72) | 43.1 (11.25) | 44.3 (10.12) |
Gender, female (%) | 64 (78.0) | 84 (69.4) | 122 (66.7) | 15 (65.2) | 285 (69.7) |
Mean duration of MS disease, years (SD) | 9.9 (7.37) | 10.0 (6.29) | 8.6 (5.74) | 9.5 (4.92) | 9.3 (6.22) |
Mean duration of treatment, years (SD) | 5.5 (2.56) | 6.8 (3.06) | 5.5 (2.93) | 5.6 (3.24) | 5.9 (2.97) |